| Trial | MAGNETISMM-7 |
|---|---|
| Cancer Type | Haematological Cancers and Myeloma |
| Hospital(s) | Belfast City Hospital |
| Information | A Randomized, 2-Arm, Phase 3 Study Of Elranatamab (Pf-06863135) Versus Lenalidomide In Patients With Newly Diagnosed Multiple Myeloma After Undergoing Autologous Stem-Cell Transplantation |